Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis

PurposeTaxanes are widely used in gynecological cancer therapy, however, taxane-induced peripheral neuropathy (TIPN) limits chemotherapy dose and reduces patients’ quality of life. As a safe and convenient intervention, cryotherapy has been recommended as a promising intervention in the recent clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Junting Jia, Yimeng Guo, Raghav Sundar, Aishwarya Bandla, Zhiying Hao
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/e6b3033b72f9472d89be439157e9c8d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e6b3033b72f9472d89be439157e9c8d1
record_format dspace
spelling oai:doaj.org-article:e6b3033b72f9472d89be439157e9c8d12021-12-01T13:40:24ZCryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis2234-943X10.3389/fonc.2021.781812https://doaj.org/article/e6b3033b72f9472d89be439157e9c8d12021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.781812/fullhttps://doaj.org/toc/2234-943XPurposeTaxanes are widely used in gynecological cancer therapy, however, taxane-induced peripheral neuropathy (TIPN) limits chemotherapy dose and reduces patients’ quality of life. As a safe and convenient intervention, cryotherapy has been recommended as a promising intervention in the recent clinical guidelines for the prevention of TIPN. Although there are a considerable number of studies which explored the use of cryotherapy in preventing chemotherapy-induced peripheral neuropathy (CIPN), there is insufficient large-scale clinical evidence. We performed a meta-analysis on the current available evidence to examine whether cryotherapy can prevent TIPN in cancer patients receiving taxanes.MethodsWe searched databases including PubMed, Embase, and Cochrane from inception to August 3, 2021 for eligible trials. Clinical trials that examined the efficacy of cryotherapy for prevention of TIPN were included. The primary outcome was the incidence of TIPN, and secondary outcomes were incidence of taxane dose reduction and changes in nerve conduction studies. The meta-analysis software (RevMan 5.3) was used to analyze the data.ResultsWe analyzed 2250 patients from 9 trials. Assessments using the Common Terminology Criteria for Adverse Events (CTCAE) score showed that cryotherapy could significantly reduce the incidence of motor and sensory neuropathy of grade≥2 (sensory: RR 0.65, 95%CI 0.56 to 0.75, p<0.00001; motor: RR 0.18, 95% CI [0.03, 0.94], p=0.04). When evaluated using the Patient Neuropathy Questionnaire (PNQ), cryotherapy demonstrated significant reduction in the incidence of sensory neuropathy (RR 0.11, 95% CI 0.04 to 0.31], p<0.0001), but did not show significant reduction in the incidence of motor neuropathy (RR 0.46, 95% CI 0.11 to 1.88, p=0.28). Cryotherapy was associated with reduced incidences of taxane dose reduction due to TIPN (RR 0.48, 95% CI [0.24, 0.95], p=0.04) and had potential to preserve motor nerves.ConclusionsCryotherapy is likely to prevent TIPN in patients receiving taxanes. High quality and sufficient amount of evidence is warranted.Junting JiaYimeng GuoRaghav SundarRaghav SundarRaghav SundarRaghav SundarAishwarya BandlaAishwarya BandlaZhiying HaoFrontiers Media S.A.articlecryotherapypreventiontaxaneperipheral neuropathymeta-analysisNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic cryotherapy
prevention
taxane
peripheral neuropathy
meta-analysis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle cryotherapy
prevention
taxane
peripheral neuropathy
meta-analysis
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Junting Jia
Yimeng Guo
Raghav Sundar
Raghav Sundar
Raghav Sundar
Raghav Sundar
Aishwarya Bandla
Aishwarya Bandla
Zhiying Hao
Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
description PurposeTaxanes are widely used in gynecological cancer therapy, however, taxane-induced peripheral neuropathy (TIPN) limits chemotherapy dose and reduces patients’ quality of life. As a safe and convenient intervention, cryotherapy has been recommended as a promising intervention in the recent clinical guidelines for the prevention of TIPN. Although there are a considerable number of studies which explored the use of cryotherapy in preventing chemotherapy-induced peripheral neuropathy (CIPN), there is insufficient large-scale clinical evidence. We performed a meta-analysis on the current available evidence to examine whether cryotherapy can prevent TIPN in cancer patients receiving taxanes.MethodsWe searched databases including PubMed, Embase, and Cochrane from inception to August 3, 2021 for eligible trials. Clinical trials that examined the efficacy of cryotherapy for prevention of TIPN were included. The primary outcome was the incidence of TIPN, and secondary outcomes were incidence of taxane dose reduction and changes in nerve conduction studies. The meta-analysis software (RevMan 5.3) was used to analyze the data.ResultsWe analyzed 2250 patients from 9 trials. Assessments using the Common Terminology Criteria for Adverse Events (CTCAE) score showed that cryotherapy could significantly reduce the incidence of motor and sensory neuropathy of grade≥2 (sensory: RR 0.65, 95%CI 0.56 to 0.75, p<0.00001; motor: RR 0.18, 95% CI [0.03, 0.94], p=0.04). When evaluated using the Patient Neuropathy Questionnaire (PNQ), cryotherapy demonstrated significant reduction in the incidence of sensory neuropathy (RR 0.11, 95% CI 0.04 to 0.31], p<0.0001), but did not show significant reduction in the incidence of motor neuropathy (RR 0.46, 95% CI 0.11 to 1.88, p=0.28). Cryotherapy was associated with reduced incidences of taxane dose reduction due to TIPN (RR 0.48, 95% CI [0.24, 0.95], p=0.04) and had potential to preserve motor nerves.ConclusionsCryotherapy is likely to prevent TIPN in patients receiving taxanes. High quality and sufficient amount of evidence is warranted.
format article
author Junting Jia
Yimeng Guo
Raghav Sundar
Raghav Sundar
Raghav Sundar
Raghav Sundar
Aishwarya Bandla
Aishwarya Bandla
Zhiying Hao
author_facet Junting Jia
Yimeng Guo
Raghav Sundar
Raghav Sundar
Raghav Sundar
Raghav Sundar
Aishwarya Bandla
Aishwarya Bandla
Zhiying Hao
author_sort Junting Jia
title Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
title_short Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
title_full Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
title_fullStr Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
title_full_unstemmed Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
title_sort cryotherapy for prevention of taxane-induced peripheral neuropathy: a meta-analysis
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/e6b3033b72f9472d89be439157e9c8d1
work_keys_str_mv AT juntingjia cryotherapyforpreventionoftaxaneinducedperipheralneuropathyametaanalysis
AT yimengguo cryotherapyforpreventionoftaxaneinducedperipheralneuropathyametaanalysis
AT raghavsundar cryotherapyforpreventionoftaxaneinducedperipheralneuropathyametaanalysis
AT raghavsundar cryotherapyforpreventionoftaxaneinducedperipheralneuropathyametaanalysis
AT raghavsundar cryotherapyforpreventionoftaxaneinducedperipheralneuropathyametaanalysis
AT raghavsundar cryotherapyforpreventionoftaxaneinducedperipheralneuropathyametaanalysis
AT aishwaryabandla cryotherapyforpreventionoftaxaneinducedperipheralneuropathyametaanalysis
AT aishwaryabandla cryotherapyforpreventionoftaxaneinducedperipheralneuropathyametaanalysis
AT zhiyinghao cryotherapyforpreventionoftaxaneinducedperipheralneuropathyametaanalysis
_version_ 1718405147066892288